Cann Group Ltd (ASX: CAN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cann Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$22.05 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
468.94 million
Earnings per share
-0.072
Dividend per share
N/A
Year To Date Return
-60.82%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cann Group Ltd (ASX: CAN)
Latest News
Share Fallers
The Cann Group share price getting smoked after a strategic shareholder exits
Share Market News
Why Althea (ASX:AGH) and these ASX cannabis shares are smoking the market today
Share Market News
ASX cannabis shares continue progress despite pandemic
Share Market News
ASX cannabis shares adjust to coronavirus environment
Share Fallers
Why Afterpay, BHP, Cann, & Mesoblast shares are tumbling lower
Share Fallers
Why Cann, Flight Centre, Helloworld, & Zip shares are dropping lower
Share Market News
Cann Group share price tanks on discounted capital raising
Share Market News
Althea share price lifts as cannabis market growth predicted
Share Market News
ASX cannabis shares see mixed recovery
Share Gainers
Why Cann, IAG, Monadelphous, & Webjet shares are storming higher
Share Market News
How did ASX cannabis shares perform in the latest quarter?
Share Market News
ASX cannabis shares stage a comeback after the March bear market
CAN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cann Group Ltd
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.
CAN Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 21 Nov 2024 | $0.05 | $0.00 | 0.00% | 98,577 | $0.05 | $0.05 | $0.05 |
| 20 Nov 2024 | $0.05 | $0.00 | 0.00% | 153,301 | $0.05 | $0.05 | $0.05 |
| 19 Nov 2024 | $0.05 | $0.00 | 0.00% | 286,446 | $0.05 | $0.05 | $0.05 |
| 18 Nov 2024 | $0.05 | $0.00 | 0.00% | 361,218 | $0.05 | $0.05 | $0.05 |
| 15 Nov 2024 | $0.05 | $0.00 | 0.00% | 469,832 | $0.05 | $0.05 | $0.05 |
| 14 Nov 2024 | $0.05 | $0.00 | 0.00% | 433,663 | $0.05 | $0.05 | $0.05 |
| 13 Nov 2024 | $0.05 | $0.00 | 0.00% | 562,307 | $0.05 | $0.05 | $0.05 |
| 12 Nov 2024 | $0.05 | $0.00 | 0.00% | 505,862 | $0.05 | $0.05 | $0.05 |
| 11 Nov 2024 | $0.05 | $0.00 | 0.00% | 645,595 | $0.05 | $0.05 | $0.05 |
| 08 Nov 2024 | $0.05 | $0.00 | 0.00% | 372,076 | $0.05 | $0.06 | $0.05 |
| 07 Nov 2024 | $0.05 | $0.00 | 0.00% | 2,238,930 | $0.05 | $0.06 | $0.05 |
| 06 Nov 2024 | $0.05 | $0.00 | 0.00% | 362,819 | $0.05 | $0.05 | $0.05 |
| 05 Nov 2024 | $0.05 | $0.00 | 0.00% | 283,767 | $0.05 | $0.05 | $0.05 |
| 04 Nov 2024 | $0.05 | $0.00 | 0.00% | 1,162,609 | $0.05 | $0.05 | $0.04 |
| 01 Nov 2024 | $0.04 | $0.00 | 0.00% | 323,897 | $0.04 | $0.04 | $0.04 |
| 31 Oct 2024 | $0.04 | $0.00 | 0.00% | 320,557 | $0.04 | $0.04 | $0.04 |
| 30 Oct 2024 | $0.04 | $0.00 | 0.00% | 89,278 | $0.04 | $0.04 | $0.04 |
| 29 Oct 2024 | $0.04 | $0.00 | 0.00% | 1,716,579 | $0.04 | $0.04 | $0.04 |
| 28 Oct 2024 | $0.04 | $0.00 | 0.00% | 575,002 | $0.04 | $0.04 | $0.04 |
| 25 Oct 2024 | $0.04 | $0.00 | 0.00% | 1,117,082 | $0.04 | $0.04 | $0.04 |
| 24 Oct 2024 | $0.04 | $0.00 | 0.00% | 936,306 | $0.04 | $0.04 | $0.04 |
| 23 Oct 2024 | $0.04 | $0.00 | 0.00% | 2,355,475 | $0.04 | $0.04 | $0.04 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 15 Nov 2024 | Douglas (Doug) Rathbone | Issued | 300,000 | $13,500 |
Issue of securities.
|
| 15 Nov 2024 | Julian Chick | Issued | 600,000 | $27,000 |
Issue of securities.
|
| 15 Nov 2024 | Jennifer (Jenni) Pilcher | Issued | 4,500,000 | $202,500 |
Issue of securities.
|
| 15 Nov 2024 | Robert Barnes | Issued | 300,000 | $13,500 |
Issue of securities.
|
| 12 Jun 2024 | Jennifer (Jenni) Pilcher | Buy | 205,500 | $9,952 |
On-market trade.
|
| 05 Jun 2024 | Robert Barnes | Buy | 200,000 | $10,000 |
On-market trade.
|
| 04 Jun 2024 | Julian Chick | Buy | 250,000 | $10,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Douglas (Doug) John Rathbone | Non-Executive Director | Mar 2015 |
Mr Rathbone is a public company director. He is the Chairman of the Rathbone Wine Group, Director of Cotton Seed Distributors, Go Resources, AgBiTech. He is also a Chairman of Health Food Holdings and Delta Agribusiness Pty Ltd. Doug is an Honorary Life Governor of the Royal Children's Hospital. He is President of My Room Children's Cancer Charity Limited and founder of Children's Cancer Foundation.
|
| Mr Allan D McCallum | Non-Executive ChairmanNon-Executive Director | Jan 2015 |
Mr McCallum has experience as a public company director in agribusiness and healthcare who has ethics, leadership capabilities and experience in strategy development and implementation, and mergers and acquisitions. Allan is also a member of Rabobank Australia Limited's Advisory Board (wholesale banking).
|
| Dr Julian John Chick | Non-Executive DirectorNon-Executive Deputy Chairman | Oct 2022 |
Dr Chick has over 25 years of experience in the biotechnology and medical technology sectors, as well as in investment banking. He has worked with public and private companies, bringing several technologies through from discovery to market, as well as experience in capital raisings, company restructuring, licensing, business development and M&A transactions. He is a member of the Risk Committee.
|
| Ms Jennifer (Jenni) Pilcher | Chief Executive OfficerManaging Director | Sep 2020 |
Ms Pilchers has over 15 years of senior finance executive experience in the medical, biotechnology and technology sectors, within small-mid cap ASX-listed companies. In addition to financial management, investor relations and corporate governance experience. Most recently, Jenni was Chief Financial Officer & Company Secretary of technology communications company Whispir Ltd (ASX:WSP), and prior to that was CFO & Company Secretary of digital imaging company, Mach7 Technologies (ASX:M7T). She has also previously held CFO roles with Australia biotechnology companies Alchemia Limited (ASX:ACL) and Mesoblast Limited (ASX:MSB).
|
| Mr Robert Gordon Barnes | Non-Executive Director | Sep 2022 |
Mr Barnes is an executive who has delivered leadership and operational outcomes across a variety of healthcare industries, including pharmaceutical, nutraceutical, infant formula, consumer, medical devices, and diagnostics. Having worked globally and in Australia in healthcare organizations, he brings diverse commercial and scientific understanding to the Company. Robert has held senior executive roles at several pharmaceutical and consumer healthcare entities including Aspen Pharmacare Australia Pty Ltd, Sanofi Australia, and Mayne Group. He has experience in the medicinal cannabis sector, being a former member of the advisory board to Leafcann Group Pty Ltd. He is Chair of the Risk Committee.
|
| Mr Steven Notaro | Company Secretary | May 2024 |
-
|
| Tony Di Pietro | Chief Financial Officer |
-
|
|
| Steven Notaro | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Ryan Prue | 14,000,000 | 3.00% |
| Mr Philip Jacobsen & Mrs Maxine Jacobsen | 11,478,943 | 2.46% |
| Mullacam Pty Ltd | 7,296,023 | 1.56% |
| Flag Capital Pty Ltd | 5,876,453 | 1.26% |
| Mr Jiashun Yang | 5,253,000 | 1.12% |
| Citicorp Nominees Pty Limited | 4,663,983 | 1.00% |
| Supernova Fund Pty Ltd | 4,341,363 | 0.93% |
| Invia Custodian Pty Limited | 4,040,000 | 0.86% |
| Adsd Soodin Holdings Pty Ltd | 3,865,051 | 0.83% |
| Ms Shengyan Hu & Mr Xiangjun Zhao | 3,550,000 | 0.76% |
| Mr Christopher John Page | 3,500,000 | 0.75% |
| T R Samuels Transport Pty Limited | 3,305,817 | 0.71% |
| Cmc Markets Stockbroking Nominees Pty Limited | 3,187,043 | 0.68% |
| Mr Michael Anderson | 2,524,620 | 0.54% |
| Hsbc Custody Nominees (Australia) Limited | 2,475,884 | 0.53% |
| Mr Xuelong Sun | 2,463,750 | 0.53% |
| Commonwealth Scientific And Industrial Research Organisation | 2,450,338 | 0.52% |
| Pacific Custodians Pty Limited | 2,183,068 | 0.47% |
| Hardmail Pty Ltd | 2,150,000 | 0.46% |
| Finclear Services Pty Ltd | 1,906,633 | 0.40% |
